CDK9/EZH2-IN-2
CDK9/EZH2-IN-2 is a potent dual CDK9 and EZH2 inhibitor with an IC50 of 8.9 nM against EZH2. CDK9/EZH2-IN-2 inhibits anti-apoptotic proteins and induces DNA damage by blocking the activity of CDK9 and EZH2, ultimately leading to tumor cell apoptosis. CDK9/EZH2-IN-2 can be used for research on diffuse large B-cell lymphoma.
For research use only. We do not sell to patients.
- Formula: C50H60ClN9O5
- Molecular Weight:902.52
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
CDK9 8.9 nM (IC50) |
EZH2 |
Caspase-3 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| U2932 | IC50 |
19.3 nM
|
Antiproliferative activity against human U-2932 cells assessed as reduction in cell viability incubated for 7 days.
Antiproliferative activity against human U-2932 cells assessed as reduction in cell viability incubated for 7 days.
|
42542216 |
| KARPAS-422 | IC50 |
9.1 nM
|
Antiproliferative activity against human KARPAS-422 cells assessed as reduction in cell viability incubated for 7 days.
Antiproliferative activity against human KARPAS-422 cells assessed as reduction in cell viability incubated for 7 days.
|
42542216 |
In Vitro
CDK9/EZH2-IN-2 (Compound A9) (7 days) exhibits potent antiproliferative activity against U-2932 (IC50 = 19.3 nM) and KARPAS-422 (IC50 = 9.1 nM) DLBCL cell lines[1].
CDK9/EZH2-IN-2 (0.1 μM; 24 h) downregulates p-Pol II Ser2, c-Myc, and Mcl-1 protein expression in U-2932 and KARPAS-422 cells[1].
CDK9/EZH2-IN-2 (15-60 nM; 48 h) dose-dependently induces apoptosis and triggers DNA damage in KARPAS-422 and U-2932 cells[1].
CDK9/EZH2-IN-2 exhibits dual inhibitory activity against EZH2 (IC50 = 8.9 nM) and CDK9 (55.4% inhibition at 100 nM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:U-2932 and KARPAS-422 cells
-
Concentration:100 nM
-
Incubation Time:48 h
-
Result:Significantly downregulated the protein expression levels of p-Pol II Ser2, c-Myc, and Mcl-1.
-
Cell Line:KARPAS-422 cells
-
Concentration:15 nM, 30 nM, 60 nM
-
Incubation Time:48 h
-
Result:Significantly increased the apoptosis rate of cells in a concentration-dependent manner.
-
Cell Line:U-2932 cells
-
Concentration:15 nM, 30 nM
-
Incubation Time:48 h
-
Result:Significantly increased the apoptosis rate of cells in a concentration-dependent manner, and its pro-apoptotic effect was stronger than the combined treatment of two single-target inhibitors.
-
Cell Line:KARPAS-422 cells
-
Concentration:15 nM, 30 nM, 60 nM
-
Incubation Time:48 h
-
Result:Promoted the cleavage of PARP and Caspase-3 (increased Cleaved-PARP and Cleaved-Caspase3 levels) in a concentration-dependent manner, while downregulating Rad51 expression and upregulating γ-H2AX levels, triggering a strong DNA damage response.
Chemical Information
-
Molecular Weight 902.52
-
Formula C50H60ClN9O5
-
SMILES
CC1=C(C(NCC2=C(C)C=C(C)NC2=O)=O)C=C(C3=CC=C(C(N[C@H]4CC[C@H](NC(NC5=CC(C6=C(CC(C)(C)C7)N7N=C6)=C(Cl)C=N5)=O)CC4)=O)C=C3)C=C1N(C8CCOCC8)CC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)